Back to news

Rocket Lab shares slide as investors continue to digest dilution, insider selling, and lower-margin guidance

Investivoq PriceTracker

Rocket Lab (RKLB) is down 14.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely drivers appear to be continuing pressure from Rocket Lab’s recent equity issuance tied to its pending Iridium acquisition, plus fresh attention on insider selling and a margin outlook that was notably below the prior quarter. There does not appear to be a single new company-specific negative announcement today, so part of the move could be investors repricing these existing overhangs all at once.

Details:

  • Rocket Lab said on September 15 that it completed a $1.944 billion at-the-market equity raise, issuing 29.3 million shares to help fund the pending Iridium acquisition, which can weigh on sentiment because it increases the share count.
  • In its latest quarterly update, Rocket Lab guided for third-quarter 2026 GAAP gross margins of 29% to 31%, down from 41.5% in the second quarter, even as it forecast another record revenue quarter.
  • An October 2 Form 4 showed Chief Financial Officer Adam Spice sold shares on October 1 under a Rule 10b5-1 trading plan, a disclosure that can add pressure when the stock is already under scrutiny.
  • This could also be because traders remain cautious about execution and financing risks around the Iridium transaction and Rocket Lab’s broader growth roadmap.

    • Sources:

    Rocket Lab Investor Relations, SEC, SEC

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $RKLB Insider Trading Activity

    RKLB Insider Trades

    $RKLB insiders have traded $RKLB stock on the open market 100 times in the past 6 months. Of those trades, 0 have been purchases and 100 have been sales.

    Here’s a breakdown of recent trading of $RKLB stock by insiders over the last 6 months:

    • PETER BECK (CEO) has made 0 purchases and 24 sales selling 3,275,779 shares for an estimated $286,410,195.
    • ADAM C. SPICE (Chief Financial Officer) has made 0 purchases and 14 sales selling 352,735 shares for an estimated $28,322,591.
    • ARJUN KAMPANI (SVP & General Counsel) has made 0 purchases and 22 sales selling 224,260 shares for an estimated $28,199,913.
    • ALEXANDER R SLUSKY has made 0 purchases and 7 sales selling 200,000 shares for an estimated $25,715,726.
    • FRANK KLEIN (Chief Operations Officer) has made 0 purchases and 20 sales selling 162,500 shares for an estimated $17,312,632.
    • MARVIN BRADFORD CLEVENGER (President, Rocket Lab USA, Inc) has made 0 purchases and 10 sales selling 34,100 shares for an estimated $3,778,202.
    • AGOSTINO RICUPATI (VP Corp Controller & CAO) has made 0 purchases and 3 sales selling 669 shares for an estimated $46,581.

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive RKLB Data Alerts
    Get market-moving data, filings, and signals for RKLB in real time.
    Sign Up

    $RKLB Hedge Fund Activity

    We have seen 762 institutional investors add shares of $RKLB stock to their portfolio, and 318 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • INVESCO LTD. added 14,745,237 shares (+409.8%) to their portfolio in Q2 2026, for an estimated $1,498,853,341
    • JPMORGAN CHASE & CO added 13,805,113 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,403,289,736
    • BAILLIE GIFFORD & CO removed 7,466,934 shares (-41.8%) from their portfolio in Q2 2026, for an estimated $759,013,841
    • CAPITAL INTERNATIONAL INVESTORS removed 6,694,910 shares (-99.9%) from their portfolio in Q2 2026, for an estimated $680,537,601
    • D. E. SHAW & CO., INC. removed 5,541,183 shares (-83.4%) from their portfolio in Q2 2026, for an estimated $563,261,251
    • DEFIANCE ETFS, LLC removed 5,055,612 shares (-89.9%) from their portfolio in Q2 2026, for an estimated $513,902,959
    • GOLDMAN SACHS GROUP INC added 3,003,173 shares (+117.5%) to their portfolio in Q2 2026, for an estimated $305,272,535

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $RKLB Government Contracts

    We have seen $20,109,601 of award payments to $RKLB over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    • VENTURE-CLASS ACQUISITION OF DEDICATED AND RIDESHARE (VADR) UMBRELLA TASK ORDER: $19,286,000

    To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.

    $RKLB Price Targets

    Multiple analysts have issued price targets for $RKLB recently. We have seen 11 analysts offer price targets for $RKLB in the last 6 months, with a median target of $120.0.

    Here are some recent targets:

    • Ryan Koontz from Needham set a target price of $120.0 on 06/30/2026
    • Trevor Walsh from Citizens set a target price of $130.0 on 06/30/2026
    • Suji Desilva from Roth Capital set a target price of $130.0 on 06/30/2026
    • Jeff Van Rhee from Craig-Hallum set a target price of $120.0 on 06/30/2026
    • Ronald Epstein from B of A Securities set a target price of $115.0 on 06/30/2026
    • Andres Sheppard from Cantor Fitzgerald set a target price of $96.0 on 06/30/2026
    • Michael Leshock from Keybanc set a target price of $135.0 on 06/15/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.